Ocular Therapeutix (OCUL) Cash from Operations (2013 - 2026)
Ocular Therapeutix's quarterly Cash from Operations came in at 65993000.0 in Q1 2026, down 47.73% year-on-year from 126256940.47 in Q1 2025, and down 21.65% quarter-over-quarter from 54249000.0 in Q4 2025.
Ocular Therapeutix has reported Cash from Operations for 14 years, with the latest figure at 65993000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 47.73% year-over-year to 65993000.0; the trailing twelve-month figure through Mar 2026 stood at 226205000.0 (down 55.51% YoY), and the FY2025 full-year result was 204883000.0, down 52.13% from the prior year.
- Cash from Operations for Q1 2026 stood at 65993000.0, down from 54249000.0 in the prior quarter.
- The five-year high for Cash from Operations was 7732000.0 in Q3 2023, with the low at 65993000.0 in Q1 2026.
- Average Cash from Operations over 5 years is 31493529.41, with a median of 24802000.0 recorded in 2024.
- Year-over-year, Cash from Operations surged 45.77% in 2022 and plunged 372.83% in 2024.
- Tracing OCUL's Cash from Operations over 5 years: stood at 16958000.0 in 2022, then tumbled by 32.41% to 22454000.0 in 2023, then tumbled by 75.6% to 39429000.0 in 2024, then plunged by 37.59% to 54249000.0 in 2025, then fell by 21.65% to 65993000.0 in 2026.
- The last three Cash from Operations figures came in at 65993000.0 (Q1 2026), 54249000.0 (Q4 2025), and 50725000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -65.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.99 Mn |
| Mar 31, 2026 | -65.99 Mn |
| Dec 31, 2025 | -54.25 Mn |
| Dec 31, 2025 | -54.25 Mn |
| Sep 30, 2025 | -50.73 Mn |
| Sep 30, 2025 | -50.73 Mn |
| Jun 30, 2025 | -55.24 Mn |
| Jun 30, 2025 | -55.24 Mn |
| Mar 31, 2025 | -44.67 Mn |
| Mar 31, 2025 | -44.67 Mn |
| Dec 31, 2024 | -39.43 Mn |
| Dec 31, 2024 | -39.43 Mn |
| Sep 30, 2024 | -36.56 Mn |
| Sep 30, 2024 | -36.56 Mn |
| Jun 30, 2024 | -24.80 Mn |
| Jun 30, 2024 | -24.80 Mn |
| Mar 31, 2024 | -33.89 Mn |
| Mar 31, 2024 | -33.89 Mn |
| Dec 31, 2023 | -22.45 Mn |
| Dec 31, 2023 | -22.45 Mn |
| Sep 30, 2023 | -7.73 Mn |
| Sep 30, 2023 | -7.73 Mn |
| Jun 30, 2023 | -20.08 Mn |
| Jun 30, 2023 | -20.08 Mn |
| Mar 31, 2023 | -19.97 Mn |
| Mar 31, 2023 | -19.97 Mn |
| Dec 31, 2022 | -16.96 Mn |
| Dec 31, 2022 | -16.96 Mn |
| Sep 30, 2022 | -13.17 Mn |
| Sep 30, 2022 | -13.17 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Mar 31, 2022 | -18.60 Mn |
| Mar 31, 2022 | -18.60 Mn |
| Dec 31, 2021 | -15.15 Mn |
| Dec 31, 2021 | -15.15 Mn |
| Sep 30, 2021 | -12.98 Mn |
| Sep 30, 2021 | -12.98 Mn |
| Jun 30, 2021 | -20.06 Mn |
| Jun 30, 2021 | -20.06 Mn |
| Mar 31, 2021 | -17.36 Mn |
| Mar 31, 2021 | -17.36 Mn |
| Dec 31, 2020 | -6.25 Mn |
| Dec 31, 2020 | -6.25 Mn |
| Sep 30, 2020 | -13.66 Mn |
| Sep 30, 2020 | -13.66 Mn |
| Jun 30, 2020 | -14.80 Mn |
| Jun 30, 2020 | -14.80 Mn |
| Mar 31, 2020 | -18.85 Mn |
| Mar 31, 2020 | -18.85 Mn |
| Dec 31, 2019 | -19.47 Mn |
| Dec 31, 2019 | -19.47 Mn |
| Sep 30, 2019 | -19.54 Mn |
| Sep 30, 2019 | -19.54 Mn |
| Jun 30, 2019 | -19.18 Mn |
| Jun 30, 2019 | -19.18 Mn |
| Mar 31, 2019 | -19.39 Mn |
| Mar 31, 2019 | -19.39 Mn |
| Dec 31, 2018 | -13.65 Mn |
| Dec 31, 2018 | -13.65 Mn |
| Sep 30, 2018 | -10.87 Mn |
| Sep 30, 2018 | -10.87 Mn |
| Jun 30, 2018 | -12.23 Mn |
| Jun 30, 2018 | -12.23 Mn |
| Mar 31, 2018 | -12.47 Mn |
| Mar 31, 2018 | -12.47 Mn |
| Dec 31, 2017 | -10.38 Mn |
| Dec 31, 2017 | -10.38 Mn |
| Sep 30, 2017 | -14.38 Mn |
| Sep 30, 2017 | -14.38 Mn |
| Jun 30, 2017 | -11.13 Mn |
| Jun 30, 2017 | -11.13 Mn |
| Mar 31, 2017 | -14.58 Mn |
| Mar 31, 2017 | -14.58 Mn |
| Dec 31, 2016 | -7.61 Mn |
| Dec 31, 2016 | -7.61 Mn |
| Sep 30, 2016 | -7.33 Mn |
| Sep 30, 2016 | -7.33 Mn |
| Jun 30, 2016 | -9.80 Mn |
| Jun 30, 2016 | -9.80 Mn |
| Mar 31, 2016 | -9.26 Mn |
| Mar 31, 2016 | -9.26 Mn |
| Dec 31, 2015 | -8.64 Mn |
| Dec 31, 2015 | -8.64 Mn |
| Sep 30, 2015 | -9.70 Mn |
| Sep 30, 2015 | -9.70 Mn |
| Jun 30, 2015 | -8.53 Mn |
| Jun 30, 2015 | -8.53 Mn |
| Mar 31, 2015 | -6.88 Mn |
| Mar 31, 2015 | -6.88 Mn |
| Dec 31, 2014 | -5.63 Mn |
| Dec 31, 2014 | -5.63 Mn |
| Sep 30, 2014 | -6.33 Mn |
| Sep 30, 2014 | -6.33 Mn |
| Jun 30, 2014 | -4.51 Mn |
| Jun 30, 2014 | -4.51 Mn |
| Mar 31, 2014 | -4.03 Mn |
| Mar 31, 2014 | -4.03 Mn |
| Dec 31, 2013 | -3.46 Mn |
| Dec 31, 2013 | -3.46 Mn |
| Sep 30, 2013 | -2.85 Mn |
| Sep 30, 2013 | -2.85 Mn |